Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 6/20 | 0.46 |
| ▸ | ATRIP | Q8WXE1 | 3/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 2/20 | 0.33 |
| ▸ | FPR3 | P25089 | 2/20 | 0.33 |
| ▸ | FPR2 | P25090 | 2/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27378350 | 1.00 | ATR (0.46) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL30797677 | 0.89 | ATR (0.41) | ATRATRIPDDB1CRBNPLK1 | |
| SCHEMBL27377014 | 0.89 | ATR (0.41) | ATRATRIPDDB1CRBNPLK1 | |
| SCHEMBL30797980 | 0.86 | ATR (0.49) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL30797746 | 0.86 | ATR (0.46) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL27378404 | 0.86 | ATR (0.46) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL30797903 | 0.86 | ATR (0.50) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL30797968 | 0.84 | ATR (0.51) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL27376610 | 0.84 | ATR (0.51) | ATRATRIPSCN9ADDB1CRBN | |
| SCHEMBL27378341 | 0.84 | SCN9A (0.38) | ATRATRIPSCN9ADDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |